Vectura Group Share Price (VEC)

179.20 -0.20 (-0.11%) delayed: 11:53PM BST
Bid price 178.50 Open price 178.90
Ask price 179.20 Prev close 179.20
High price 179.60 Spread 0.39%
Low price 176.70 Volume 267,327

Register now for FREE live Vectura Group share prices, Vectura Group stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Vectura Group Level 2 Data, indepth research tools and investor commentary for Vectura Group (VEC) and other London Stock Exchange equities.

Vectura Group Share Price Chart

Advanced Charts >>

Register now for FREE Vectura Group share price charts

Vectura Group Share Price Information

Name Vectura Group Epic VEC
Sector Pharmaceuticals & Biotechnology ISIN GB00B01D1K48
Activites Vectura Group plc develops inhaled therapies principally for the treatment of respiratory diseases. Vectura's main products target diseases such as asthma and chronic obstructive pulmonary disease (COPD), a growing market that is currently estimated to be worth in excess of $25bn. Vectura has seven products marketed by its partners and a portfolio of drugs in clinical and pre-clinical development, a number of which have been licensed to major pharmaceutical companies. Vectura has development collaborations and licence agreements with several pharmaceutical companies, including Novartis, Sandoz (the generics arm of Novartis), Baxter and GlaxoSmithKline (GSK). Vectura seeks to develop certain programmes itself where this will optimise value. Vectura's formulation and inhalation technologies are available to other pharmaceutical companies on an out-licensing basis where this complements Vectura's business strategy. Index FTSE 250

Vectura Group Key Numbers

Latest Share Price (p) 179.20 Net Gearing (%) -6.27
Market Capitalisation (£m) 720.24 Gross Gearing (%) 24.40
Shares in issue (m) 404.52 Debt Ratio 10.20
P/E Ratio 197.83 Debt-to-Equity Ratio 0.35
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.32
Dividend Yield (%) 0.00 Price to book value 3.25
Dividend cover (x) 0.00 ROCE -0.03
Earning per share (p) 0.90 EPS Growth (%) 228.57
52 week high / low 183.75 / 113.75 DPS Growth (%) n/a

Vectura Group Director Deals

Dec.Date Type Director Pos No. of Shares
17/04/2015 EXR Dr Christopher Blackwell RES 18,987
16/01/2015 EXR Dr Trevor Phillips ED 3,133
16/01/2015 EXR Dr Trevor Phillips ED 208,877
16/01/2015 SEXR Dr Trevor Phillips ED 171,777
08/07/2014 BUY Dr Christopher Blackwell RES 1,212

More Vectura Group Director Deals >>

Vectura Group Company News

07:00 01/07/2015

Voting Rights and Capital

/* */ RNS Number : 7314R Vectura Group plc 01 July 2015     Vectura Group plc (the "Company")   VOTING RIGHTS AND CAPITAL     Chippenham, UK, 1 July 2015: In accordance with the Financial Conduct Authority's Transparency...

12:43 26/06/2015

TR-1 Notification of Major Interest in Shares

/* */ RNS Number : 3743R Vectura Group plc 26 June 2015   For filings with the FCA include the annex For filings with the issuer exclude the annex   TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i...

12:47 24/06/2015

AstraZeneca man becomes CEO at Vectura

Vectura Group (LSE: VEC), which specialises in the development of products for the treatment of airways-related diseases, has appointed James Ward-Lilley as CEO. He will succeed Dr Chris Blackwell who, as previously announced, leaves Vectura at the end of this month. Mr Ward-Lilley will join...

More Vectura Group Company News >>

Register now for FREE Vectura Group company news

Vectura Group Share Price Discussions

3 months ago


Powered by IST's

Register now for FREE Vectura Group share price discussions